Deflox

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Deflox

Quick Facts

Property Description
Active Ingredient Diclofenac (Sodium or Potassium salt)
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Origin Synthetic (Phenylacetic Acid Derivative)
Common Use Symptomatic relief of pain, inflammation, and fever
Forms Tablet, Capsule, Injectable Solution, Topical Gel, Ophthalmic Solution

The Identity of Deflox: Classification and Origin

Deflox is a synthetic medicinal product whose active pharmaceutical ingredient is Diclofenac, a substance formally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This classification describes its pharmacological role. Diclofenac is structurally derived from phenylacetic acid, which defines its unique structure within the broader NSAID group. The medication's function is clinically recognized for its potent inhibition of cyclooxygenase (COX) enzymes, which reduces the production of chemical compounds that mediate pain, inflammation, and fever signals.

Composition and Available Forms of Deflox

The core of Deflox is the active substance Diclofenac, typically present as its sodium or potassium salt. The medicine is manufactured in multiple pharmaceutical preparations, enabling varied methods of delivery. These forms include options for systemic absorption, such as oral tablets and injectable solutions, designed for generalized relief. It is also available in preparations for localized action, including topical gels and ophthalmic solutions for the eyes. This range of forms allows for either comprehensive relief or a targeted concentration of the active ingredient at a specific area of localized discomfort.

General Purpose and Therapeutic Focus

The general purpose of Deflox is to mitigate inflammation, relieve general pain, and reduce fever through its targeted biochemical action against prostaglandin synthesis. Its primary utility is in the symptomatic management of discomfort. The active ingredient possesses a triple action of being anti-inflammatory, analgesic, and antipyretic. This defining therapeutic focus is consistent across its various formulations.

Regulatory References

  1. MedlinePlus, Diclofenac
  2. FDA, Diclofenac Monograph

What side effects are possible with Deflox?

Deflox: Possible Side Effects and Safety Information

Deflox belongs to the fluoroquinolone class of antibiotics, which is associated with a specific set of serious adverse reactions. Official regulatory documentation requires the strongest warning (Boxed Warning) for the potential for disabling and potentially irreversible serious adverse reactions that can occur together and involve multiple body systems.

These serious risks include:

  • Tendinitis and Tendon Rupture: Inflammation or tearing of tendons, which can occur during or after treatment, particularly in patients over 60, those with kidney, heart, or lung transplants, or those taking corticosteroids.
  • Peripheral Neuropathy: Nerve damage outside the brain and spinal cord, which may result in symptoms like pain, burning, tingling, or numbness in the arms or legs.
  • Central Nervous System (CNS) Effects: Psychiatric and neurological reactions such as anxiety, depression, confusion, and hallucinations.
  • Exacerbation of Myasthenia Gravis: Worsening of muscle weakness in patients with this condition.

Commonly Observed Adverse Reactions

Adverse reactions reported in clinical trials, occurring in 2% or more of patients, typically involve the gastrointestinal and nervous systems. These may include nausea, vomiting, diarrhea, headache, and dizziness.

Other Safety Considerations

Deflox is also associated with other serious adverse reactions, including: severe hypersensitivity reactions (anaphylaxis) that can be fatal, Clostridium difficile-associated diarrhea, and blood glucose disturbances. Due to potential risks, the drug is contraindicated in patients with a known history of hypersensitivity to Deflox or other fluoroquinolones. Specific caution is required for patients with pre-existing conditions like tendon disorders, myasthenia gravis, or severe renal impairment, where dosage adjustment or avoidance is officially advised.

Overdose and Emergency Response

The official regulatory profile for Deflox overdose focuses on documented clinical manifestations and the immediate, mandated requirement to seek professional emergency intervention.

Documented Overdose Manifestations

Acute ingestion may result in Gastrointestinal disturbances such as nausea, vomiting, and epigastric pain. More serious presentations can involve Gastrointestinal hemorrhage. Central Nervous System effects documented in official labeling include headache, drowsiness, confusion, dizziness, and tinnitus. Overdose in significant quantity carries a risk of severe, life-threatening outcomes, including Acute Renal Failure, Hepatic Dysfunction, Hypotension, and the potential for Convulsions or Coma.

Required Emergency Actions

In any situation of suspected or confirmed overdose, official regulatory guidance requires the user to seek immediate medical attention and contact emergency services. No specific antidote is known for Diclofenac overdose; therefore, management relies entirely on officially described symptomatic and supportive treatment. Medical procedures may include the potential use of activated charcoal for gastric decontamination and close monitoring of vital signs and organ function.

Population Considerations

Official labeling notes that the elderly and patients with pre-existing hepatic or renal impairment may face an increased risk of severe toxicity in an overdose scenario.

Therapeutic Uses of Deflox

Deflox (Diclofenac) is commonly used to provide supportive symptom management in clinical situations marked by pain, inflammation, and fever. Its use is relevant in contexts that involve symptoms that may interfere with comfort and daily routines. The medication is indicated for use in therapeutic domains where symptoms cause noticeable physiological strain.


The medication helps address groups of symptoms in chronic conditions such as Osteoarthritis and Rheumatoid Arthritis, and in acute episodes like sprains, gout flares, and primary dysmenorrhea (menstrual cramps). In acute scenarios, such as the relief of pain and swelling post-surgery, Deflox supports the patient during periods of heightened discomfort, contributing to symptomatic relief. The primary therapeutic focus is to help manage manifestations that may include swelling, joint stiffness, pain, and fever. The medication is applied in various situations where additional symptomatic assistance is needed.

Quick Fact: Supportive Relief Focus
Primary Symptom Focus Pain, Inflammation, Fever
Core Therapeutic Benefit Symptomatic Support
Typical Context Chronic Musculoskeletal Conditions and Acute Episodes

Regulatory References

  1. NIH MedlinePlus overview on Diclofenac

Eligibility and Restrictions for Use

Deflox (Diclofenac) eligibility is strictly defined by regulatory authorities.

Contraindicated Populations

Deflox is contraindicated and must not be used by individuals with a known hypersensitivity to diclofenac or a history of allergic reactions, such as asthma or hives, precipitated by aspirin or other NSAIDs. Use is also prohibited in patients immediately following Coronary Artery Bypass Graft (CABG) surgery and those with active peptic ulceration, gastrointestinal bleeding, or perforation. Absolute contraindications apply to individuals with severe cardiac, hepatic, or renal failure.

Age and Physiological Restrictions

Deflox is generally indicated for adults. Specific forms may be approved for adolescents, but safety and efficacy are often not established for children under 12 years of age. Older adults (65 years and over) should use the medicine with caution due to increased risks. Deflox is contraindicated in women during the third trimester of pregnancy (after 30 weeks gestation), and avoidance is advised from 20 weeks. Use is generally not recommended while breastfeeding.

Conditional Use

Conditional use and close monitoring apply to patients with a history of GI events, established cardiovascular risk factors, or pre-existing fluid retention. Use is not recommended in patients with advanced renal disease.

What should I know about interactions with other medicines?

Deflox Interactions with other medicines and products

The interaction profile of Deflox (Diclofenac) details combinations that pose specific, officially documented risks, primarily relating to altered drug exposure and the reinforcement of adverse effects.

Contraindications and High-Risk Combinations

Co-administration is formally contraindicated for treating perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. This medication is also prohibited for patients with a history of allergic-type reactions (asthma, urticaria) to Aspirin or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Consumption of Alcohol carries an increased risk of serious gastrointestinal bleeding.

Interaction Type Interacting Agent Official Outcome Described
Pharmacodynamic Other NSAIDs, SSRIs, Anticoagulants Increased risk of bleeding or gastrointestinal ulceration.
Exposure Alteration Lithium, Digoxin, Methotrexate Increased serum concentrations of the co-administered drug due to reduced renal clearance.
Metabolic (PK) Voriconazole (Enzyme Inhibitor) Documented significant increase in Diclofenac plasma exposure (Cmax and AUC).
Renal Risk Diuretics, Ciclosporin, ACE Inhibitors Increased risk of nephrotoxicity or renal impairment.

Population-Specific Constraints

Regulatory documents note that elderly patients face a higher incidence of serious gastrointestinal events. Furthermore, the risk of renal injury when combined with Diuretics, ACE Inhibitors, or ARBs is heightened in individuals with compromised renal or cardiac function. Certain oral formulations may require administration on an empty stomach to avoid reduced effectiveness caused by food delaying absorption.

Mechanism of Action

Inhibition of the Prostanoid Synthesis Pathway

Deflox's primary mechanism involves the competitive inhibition of the Cyclooxygenase (COX) enzymes, where the molecule interacts with the active site of both COX-1 and COX-2 isoforms. This action suppresses the synthesis of Prostaglandin E2 (PGE2), a critical prostanoid mediator within the Arachidonic Acid Cascade. The resulting cascade includes the modulation of local vasodilation and a reduction in the chemical sensitization of peripheral nociceptors.

Direct Modulation of Neuronal Signaling

A separate mechanistic domain involves the molecule’s direct influence on the electrical components of neuronal signaling. Deflox acts as an inhibitor of specific neuronal ion channels, including Voltage-Dependent Sodium Channels. This molecular action stabilizes the nerve cell membrane, decreasing its excitability and limiting the propagation of electrical signals. This mechanism influences signal propagation within nociceptive neurons centrally and peripherally.

Central Thermoregulatory Pathway Engagement

The high lipid solubility of the active ingredient allows the mechanism to extend into the Central Nervous System (CNS), focusing on the Hypothalamic Thermoregulatory Center. Here, the inhibition of PGE2 synthesis removes the molecular signal that mediates the elevation of the body's thermal setpoint. This central action permits the adjustment of the elevated thermal setpoint toward baseline physiological regulation.

Dosage and Administration Information

How to Use Deflox: Official Administration Guidelines

Deflox (Diclofenac) usage follows established administration guidelines that dictate the appropriate dosage, form, route, and duration of use.


Administration Routes and Standard Dosing

The medicine is administered through multiple routes, including Oral, Intravenous (IV), Intramuscular (IM), Topical, and Rectal preparations. The precise strength and frequency depend on the clinical context and form used. For Osteoarthritis, oral dosing typically falls in the range of 100 mg to 150 mg per day in divided doses. For Acute Pain, an IV bolus of 37.5 mg may be administered every 6 hours, with a maximum daily IV dose of 150 mg.


Frequency, Timing, and Duration

Treatment frequency is determined by the formulation: Extended-release tablets are typically taken once daily, while standard oral forms require divided daily dosing to maintain consistent levels. Certain oral forms, such as the powder for solution, must be taken on an empty stomach. Injectable forms (IM/IV) are intended for short-term treatment and generally do not exceed two days, transitioning to oral or rectal forms thereafter. This use pattern ensures the lowest effective dose is used for the shortest duration possible.


Special Procedural Instructions

Official labeling contains specific instructions for proper use. Delayed-release and extended-release tablets must always be swallowed whole and must not be crushed, chewed, or divided. For the oral solution powder, it must be mixed with water only (1 to 2 ounces), and patients receiving the IV formulation must be well hydrated prior to administration. For older adults, the lowest effective dosage for the shortest possible duration is a recognized clinical protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Deflox

Evidence for Symptomatic Relief in Chronic Musculoskeletal Conditions

Research on Deflox (Diclofenac) for the symptoms related to Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Ankylosing Spondylitis (AS) has primarily used short-term and intermediate-term randomized controlled trials (RCTs). These studies were designed to track changes in patient-reported outcomes related to physical discomfort and daily functioning. Additionally, large-scale systematic reviews and meta-analyses were applied in studies examining patient-reported experiences across multiple trials.

Studies for Osteoarthritis and Functional Measures

For Osteoarthritis (OA), researchers measured outcomes related to physical discomfort using specialized tools like the WOMAC functional scores and pain intensity scales. Both oral and topical formulations were evaluated in these studies, which were conducted on adult populations, including older adults. Findings describe patterns observed in the studies where measurements of pain scores and functional scores were evaluated across periods often lasting up to six months. However, the available data for certain groups remain insufficient, and long-term effects are not fully established by controlled trials.

Studies for Rheumatoid Arthritis and Inflammatory Markers

Deflox was studied for Rheumatoid Arthritis (RA) in trials designed to track changes in both patient-reported outcomes and objective measures related to systemic or functional imbalance. Research examined physical outcomes such as the count of tender and swollen joints and components of global disease activity assessments. Studies conducted during periods of increased symptom activity described changes measured during the study period. Research provides context but not individual predictions regarding a similar response.

Evidence for Acute Pain and Short-Term Symptom Management

Research has explored Deflox for conditions associated with acute or disruptive episodes, where symptoms may vary in intensity. This research relies mainly on acute-dose randomized controlled trials to track changes over short time intervals. For Primary Dysmenorrhea (menstrual pain), the medicine was evaluated in studies focusing on episodes where symptoms become more noticeable, tracking outcomes related to physical discomfort. Research also describes patterns related to how symptoms were measured to change over defined time intervals in the observed populations for acute pain and migraine headache attacks.

Key Studies & References Diclofenac - StatPearls - NCBI Bookshelf - NIH (General indications/RA/AS)

Frequently Asked Questions (FAQ)

Common questions about Deflox (FAQ)

Q: Is Deflox safe to use if I am also taking over-the-counter pain relievers?

Regulatory documents state that co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is not recommended. This is because taking Deflox with other NSAIDs, including those often found in over-the-counter combination products, may significantly increase the risk of serious side effects like gastrointestinal bleeding or kidney injury.


Q: Is there a generic version of Deflox available, or is it only sold under the brand name?

The active ingredient in Deflox is diclofenac. The official product information confirms that diclofenac is available in various products under both brand names and as a generic version.


Q: What is the latest research or clinical evidence available regarding Deflox?

Studies and official information indicate that the active ingredient, diclofenac, is subject to ongoing research. This includes continuous safety reviews, particularly regarding cardiovascular risk, and its potential application in new therapeutic areas like infectious or neurodegenerative diseases.


Q: Are there any known long-term risks associated with taking Deflox?

Yes, official documents warn that long-term use or use at high doses is associated with an increased risk of serious adverse events. These events include gastrointestinal ulceration and bleeding, as well as a heightened risk of heart or kidney failure.


Q: Does Deflox affect the ability to drive or operate machinery?

Official product information states that Deflox may cause side effects such as tiredness, dizziness, sleepiness, or blurred vision. If these effects occur, official product information recommends caution regarding activities like driving or operating machinery.


Q: How is the medicine Deflox described to work in the body, in simple terms?

In simple terms, the medicine works mainly by reducing the production of natural chemical compounds called prostaglandins. Prostaglandins are responsible for signaling and mediating inflammation, pain, and fever in the body.


Q: How long is Deflox typically used for (short-term vs. chronic treatment)?

The required duration of use varies depending on the medical condition. For acute, short-term issues, it is generally used for a short time. For chronic conditions, it is generally used for periods determined by a healthcare provider, consistent with the principle of using the lowest effective dose for the shortest duration necessary.


Q: Why do some people refer to Deflox as a 'slow-acting' medicine?

The active ingredient, diclofenac, is manufactured in various pharmaceutical forms, including extended-release or slow-release tablets and capsules. These forms are specifically designed to release the medicine into the body gradually over a longer period, which may lead to the perception of a 'slow-acting' effect.


Q: Can Deflox be taken with common beverages like coffee or juice?

Official administration guidelines for oral forms often recommend taking the medicine with food or milk to help reduce potential stomach irritation. For the powder for oral solution, the product label indicates that only water should be used for mixing the oral powder form.


Q: Is the effectiveness of Deflox influenced by diet or physical activity?

Regulatory information indicates that taking the medication with food may cause a delay in how quickly the active ingredient is absorbed into the bloodstream. There is no official regulatory information available on the influence of physical activity.


Q: Does Deflox affect blood pressure or blood sugar levels?

Official warnings state that Deflox is associated with a risk of new or worsened high blood pressure (hypertension). Additionally, the medicine is associated with a risk of disturbances in blood glucose levels.


Q: What is the typical duration of treatment expected for a chronic condition using Deflox?

For chronic conditions such as rheumatoid arthritis, treatment may be prescribed for longer periods to manage symptoms. Treatment is aligned with the regulatory principle of using the lowest effective dosage for the shortest duration necessary.


Q: Does Deflox interact with common over-the-counter cold and flu medicines?

Many over-the-counter cold and flu medicines contain non-steroidal anti-inflammatory drugs (NSAIDs). Official drug interaction documents state that combining Deflox with other NSAIDs is not recommended due to a significantly increased risk of serious adverse effects.


Q: How long does it typically take for Deflox to start working after the first dose?

Based on regulatory data, the medicine is characterized by relatively rapid absorption. For some oral forms, the concentration of the active ingredient in the blood reaches its peak approximately one hour after dosing.


Q: What should be expected if a dose is missed (general information)?

Official instructions typically advise taking a missed dose as soon as it is remembered, unless it is nearly time for the next scheduled dose. Patients are generally directed not to take a double dose to compensate for the missed one.


Q: Does Deflox interact with herbal supplements or vitamins?

Official drug interaction reports have documented potential risks when Deflox is taken with certain supplements. This includes glucosamine, omega-3 fatty acids, and high doses of vitamin E.


Q: Is Deflox the same type of medicine as [similar generic drug name]?

Deflox is formally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Its active ingredient, diclofenac, is structurally a derivative of phenylacetic acid, which defines its specific type within the broader NSAID class.


Q: Does Deflox cause weight changes (gain or loss) as a reported side effect?

Adverse event reports reviewed by regulatory agencies have included weight changes as a possible side effect. Further details regarding reported adverse events can be found in the official prescribing information.


Q: Is there an official Medication Guide or Patient Information Leaflet for Deflox?

Yes, official patient information documents, such as a Medication Guide or Patient Information Leaflet, are available for Diclofenac products. These are provided by regulatory bodies to explain how to use the medicine safely.


Q: Will Deflox affect the effectiveness of birth control pills?

Severe gastrointestinal side effects like vomiting or diarrhea may reduce the effectiveness of oral contraceptives. Official documents also note that Deflox may interact with contraceptives containing drospirenone, potentially leading to increased potassium levels.


Q: Are there any laboratory tests that are typically recommended while taking Deflox?

Official guidance advises close monitoring of blood pressure when starting treatment and throughout the course of therapy. Additionally, regulatory documents advise monitoring liver function while taking the medicine.


Q: What is the process for reporting a suspected side effect from Deflox?

Suspected side effects can be reported voluntarily or mandatorily to the relevant regulatory authority. In the United States, this is done through the Food and Drug Administration (FDA) via their official reporting system (MedWatch).


Q: Are there any patient registries or ongoing studies for Deflox?

The active ingredient, diclofenac, is subject to ongoing research regarding its safety, specifically cardiovascular risk, and its potential application in non-traditional areas like infectious or neurodegenerative diseases.


Q: What is a drug-condition interaction and how does it relate to Deflox?

A drug-condition interaction describes a situation where a pre-existing medical condition may be negatively affected by the medicine. For Deflox, official documents prohibit its use in patients with severe heart failure or active gastrointestinal bleeding, which serve as examples of such interactions.


Q: Is Deflox likely to cause sleepiness or fatigue?

Side effects reported in clinical trials and adverse event reports include sleepiness and tiredness.


Q: Are there any restrictions on sun exposure while taking Deflox?

Official adverse reaction reports have included the risk of photosensitivity. Patients using the medicine, particularly the topical forms, may need to be cautious regarding sun exposure.


Q: How quickly do the side effects of Deflox usually disappear after stopping the medicine?

The terminal half-life of the active ingredient, which is a measure of how quickly the drug is eliminated from the body, is approximately 1.9 hours.


Q: Where can I find the official prescribing information for Deflox?

Official prescribing information, such as the full FDA label (Package Insert/Prescribing Information) or the Summary of Product Characteristics (SmPC) in the EU, can be accessed through government regulatory websites.

How should Deflox be stored and disposed of?

How to Store and Dispose of Deflox (Diclofenac)

The storage and handling of Deflox (Diclofenac oral solid forms) must follow regulatory requirements to maintain product stability and ensure safety.


Official Storage Requirements

Storage Component Requirement
Temperature Store at room temperature, typically 20 C to 25 C (68 F to 77 F), not exceeding 30 C.
Protection Protect from light and moisture; keep the product from freezing and away from excessive heat.
Packaging Store in the original container and ensure the receptacle is tightly closed.
Safety Keep this medicine out of the sight and reach of children.

Official Disposal Instructions

Expired or unused Deflox should not be thrown away via wastewater or household waste without following specific procedures. The recommended method is to use a community-based drug take-back program. If a take-back program is unavailable, federal guidelines permit mixing the medicine with an undesirable substance (such as used coffee grounds) in a sealed bag before disposal in the household trash. Always remove personal information from the packaging before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Deflox found in:

A-Z Index: